Royalty Pharma

Aktuelle Nachrichten

Schlagzeilen in der Originalsprache der Quelle.

• Royalty Pharma Owns a Piece of 16 Blockbuster Drugs -- Is the Stock a Buy? (öffnet in neuem Tab)

  The Motley Fool · 01.10.2026

• Form 4 Royalty Pharma Plc For: 1 October By Investing.com (öffnet in neuem Tab)

  Investing.com Nigeria · 01.10.2026

• Royalty Pharma EVP Marshall Urist sells $238,812 in shares (öffnet in neuem Tab)

  Investing.com · 30.09.2026

• Royalty Pharma (NASDAQ:RPRX) EVP Marshall Urist Sells 4,126 Shares of Stock (öffnet in neuem Tab)

  MarketBeat · 30.09.2026

• Form 4 Royalty Pharma Plc For: 30 September By Investing.com (öffnet in neuem Tab)

  Investing.com UK · 30.09.2026

• A director acquires 642 shares in lieu of a $37,500 retainer at Royalty Pharma (RPRX). (öffnet in neuem Tab)

  Stock Titan · 30.09.2026

• 4,126 shares sold under a trading plan by Royalty Pharma (RPRX) EVP Marshall Urist. (öffnet in neuem Tab)

  Stock Titan · 30.09.2026

• RPRX: Blockbuster Royalties Were The Hook, Synthetic Financing Drives The Upside (öffnet in neuem Tab)

  Simply Wall Street · 30.09.2026

• If You Invested $100 In Royalty Pharma Stock 10 Years Ago, You Would Have This Much Today (öffnet in neuem Tab)

  Benzinga · 29.09.2026

• After tax other income/expense of Royalty Pharma Plc Class A – HAN:RPD (öffnet in neuem Tab)

  TradingView · 29.09.2026

• Form 144 Royalty Pharma plc For: 29 September By Investing.com (öffnet in neuem Tab)

  Investing.com Canada · 29.09.2026

• Royalty Pharma officer proposes $239K share sale | RPRX SEC Filing - Form 144 (öffnet in neuem Tab)

  Stock Titan · 28.09.2026

• Form 144 Royalty Pharma PLC For: 27 September By Investing.com (öffnet in neuem Tab)

  Investing.com UK · 27.09.2026

• Royalty Pharma (NASDAQ:RPRX) Rating Lowered to Buy at Wall Street Zen (öffnet in neuem Tab)

  MarketBeat · 26.09.2026

• Did AI Expansion Just Shift Royalty Pharma's (RPRX) Investment Narrative? (öffnet in neuem Tab)

  Simply Wall Street · 26.09.2026

• Form 4 Royalty Pharma Plc For: 25 September By Investing.com (öffnet in neuem Tab)

  Investing.com India · 25.09.2026

• Royalty Pharma EVP Christopher Hite sells $5.85m in shares (öffnet in neuem Tab)

  Investing.com · 25.09.2026

• Revolution Medicines Receives FDA Breakthrough Designation, Royalty Pharma Offers a Diversified Investment Path (öffnet in neuem Tab)

  NAI500 · 25.09.2026

• Royalty Pharma Eyes AI, China Growth While Navigating Biopharma Policy Shifts (öffnet in neuem Tab)

  es.tradingview.com · 25.09.2026

• Is Buying Royalty Pharma Stock a Safer Way to Bet on Revolution Medicines? (öffnet in neuem Tab)

  The Motley Fool · 25.09.2026

• Insider Selling: Royalty Pharma (NASDAQ:RPRX) EVP Sells $5,853,000.00 in Stock (öffnet in neuem Tab)

  MarketBeat · 24.09.2026

• Royalty Pharma(RPRX.US) Officer Sells US$5.85 Million in Common Stock (öffnet in neuem Tab)

  Moomoo · 24.09.2026

• A prearranged plan governed SCH Investment Partners’ sale of 100,000 Royalty Pharma (RPRX) shares. (öffnet in neuem Tab)

  Stock Titan · 24.09.2026

• Royalty Pharma at Bank of America Global Healthcare Conference: growth even with policy risks (öffnet in neuem Tab)

  Investing.com UK · 23.09.2026

• Andra AP fonden Lowers Stock Holdings in Royalty Pharma PLC $RPRX (öffnet in neuem Tab)

  MarketBeat · 23.09.2026

• Royalty Pharma (RPRX) Stock Looks Richly Priced After Its 136% Run (öffnet in neuem Tab)

  Yahoo Finance · 23.09.2026

• Royalty Pharma (RPRX) holder plans new sale after selling 350,000 shares (öffnet in neuem Tab)

  Stock Titan · 22.09.2026

• NewEdge Advisors LLC Raises Stock Position in Royalty Pharma PLC $RPRX (öffnet in neuem Tab)

  MarketBeat · 21.09.2026

• Royalty Pharma PLC $RPRX Shares Sold by Corient Private Wealth LP (öffnet in neuem Tab)

  MarketBeat · 19.09.2026

• Could Royalty Pharma’s (NASDAQ:RPRX) Story Be Changing Fast? (öffnet in neuem Tab)

  kalkinemedia.com · 18.09.2026